Stay updated on MAPK Pathway Inhibitors in Hematologic Malignancies Clinical Trial

Sign up to get notified when there's something new on the MAPK Pathway Inhibitors in Hematologic Malignancies Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the MAPK Pathway Inhibitors in Hematologic Malignancies Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    The page history shows a new revision label Revision: v3.3.2 added and the prior Revision: v3.3.1 removed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-12-01T17:42:34.000Z thumbnail image
  2. Check
    14 days ago
    Change Detected
    Summary
    A new site revision entry (Revision: v3.3.1) was added and the previous revision (Revision: v3.2.0) was removed from the history. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-11-24T14:50:41.000Z thumbnail image
  3. Check
    21 days ago
    Change Detected
    Summary
    Notice about government funding lapse and potential data delays was removed from the page.
    Difference
    0.8%
    Check dated 2025-11-17T06:56:24.000Z thumbnail image
  4. Check
    35 days ago
    Change Detected
    Summary
    A new history entry dated 2022-06-13 was added, updating the Study Status and referencing prior Recruitment Status changes in the record.
    Difference
    0.1%
    Check dated 2025-11-03T01:21:14.000Z thumbnail image
  5. Check
    64 days ago
    Change Detected
    Summary
    - Added a government operating status notice and a link to official sources for NIH Clinical Center status. - Updated version to v3.2.0 and removed reference to v3.1.0.
    Difference
    13%
    Check dated 2025-10-05T10:29:40.000Z thumbnail image
  6. Check
    71 days ago
    Change Detected
    Summary
    Update: revision tag changed from v3.0.2 to v3.1.0. No other content changes detected.
    Difference
    0.3%
    Check dated 2025-09-28T03:24:03.000Z thumbnail image

Stay in the know with updates to MAPK Pathway Inhibitors in Hematologic Malignancies Clinical Trial

Enter your email address, and we'll notify you when there's something new on the MAPK Pathway Inhibitors in Hematologic Malignancies Clinical Trial page.